Bingru Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bingru Zhao has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Leyi Gu
Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
2 shared publications Ahui Song
Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Renji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiaotong University, School of Medicine, China
1 shared publication- Ahui Song
Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Uremia Diagnosis and Treatment Center, Ren Ji Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
1 shared publication - Cheng Qian
Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Uremia Diagnosis and Treatment Center, Ren Ji Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
1 shared publication - Huili Dai
Shanghai University of Traditional Chinese Medicine, Shanghai, China
1 shared publication Jiayue Lu
Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Renji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiaotong University, School of Medicine, China
1 shared publication
Latest Publications
- 1 October 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (19) , e70085
Exosomal let‐7b‐5p deriving from parietal epithelial cells attenuate renal fibrosis through suppression of TGFβR1 and ARID3a in obstructive kidney disease
As renal progenitor cells, parietal epithelial cells (PECs) have demonstrated multilineage differentiation potential in response to kidney injury. However, the function of exosomes derived from PECs has not been extensively explored. Immunofluorescent staining of Claudin‐1 was used to identify primary PECs isolated from mouse glomeruli. Transmission electron microscopy, nanoparticle tracking analysis, and western blotting were used to characterize the properties of PECs‐derived exosomes (PEC‐Exo). The therapeutic role of PEC‐Exo in tubulointerstitial fibrosis was investigated in the unilateral ureteral obstruction (UUO) mouse model and TGF‐β1‐stimulated HK‐2 cells. High‐throughput miRNA sequencing was employed to profile PEC‐Exo miRNAs. One of the most enriched miRNAs in PEC‐Exo was knocked down by transfecting miRNA inhibitor, and then we investigated whether this candidate miRNA was involved in PEC‐Exo‐mediated tubular repair. The primary PECs expressed Claudin‐1, PEC‐Exo was homing to obstructed kidney, and TGF‐β1 induced HK‐2 cells. PEC‐Exo significantly alleviated renal inflammation and ameliorated tubular fibrosis both in vivo and in vitro. Mechanistically, let‐7b‐5p, highly enriched in PEC‐Exo, downregulated the protein levels of transforming growth factor beta receptor 1(TGFβR1) and AT‐Rich Interaction Domain 3A(ARID3a) in tubular epithelial cells (TECs), leading to the inhibition of p21 and p27 to restoring cell cycle. Furthermore, administration of let‐7b‐5p agomir mitigated renal fibrosis in vivo. Our findings demonstrated that PEC‐derived exosomes significantly repressed the expression of TGFβR1 and ARID3a by delivering let‐7b‐5p, thereby alleviating renal fibrosis. This study provides novel insights into the role of PEC‐Exo in the repair of kidney injury and new ideas for renal fibrosis intervention.
- 1 October 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (19) , e70085
Exosomal let‐7b‐5p deriving from parietal epithelial cells attenuate renal fibrosis through suppression of TGFβR1 and ARID3a in obstructive kidney disease
As renal progenitor cells, parietal epithelial cells (PECs) have demonstrated multilineage differentiation potential in response to kidney injury. However, the function of exosomes derived from PECs has not been extensively explored. Immunofluorescent staining of Claudin‐1 was used to identify primary PECs isolated from mouse glomeruli. Transmission electron microscopy, nanoparticle tracking analysis, and western blotting were used to characterize the properties of PECs‐derived exosomes (PEC‐Exo). The therapeutic role of PEC‐Exo in tubulointerstitial fibrosis was investigated in the unilateral ureteral obstruction (UUO) mouse model and TGF‐β1‐stimulated HK‐2 cells. High‐throughput miRNA sequencing was employed to profile PEC‐Exo miRNAs. One of the most enriched miRNAs in PEC‐Exo was knocked down by transfecting miRNA inhibitor, and then we investigated whether this candidate miRNA was involved in PEC‐Exo‐mediated tubular repair. The primary PECs expressed Claudin‐1, PEC‐Exo was homing to obstructed kidney, and TGF‐β1 induced HK‐2 cells. PEC‐Exo significantly alleviated renal inflammation and ameliorated tubular fibrosis both in vivo and in vitro. Mechanistically, let‐7b‐5p, highly enriched in PEC‐Exo, downregulated the protein levels of transforming growth factor beta receptor 1(TGFβR1) and AT‐Rich Interaction Domain 3A(ARID3a) in tubular epithelial cells (TECs), leading to the inhibition of p21 and p27 to restoring cell cycle. Furthermore, administration of let‐7b‐5p agomir mitigated renal fibrosis in vivo. Our findings demonstrated that PEC‐derived exosomes significantly repressed the expression of TGFβR1 and ARID3a by delivering let‐7b‐5p, thereby alleviating renal fibrosis. This study provides novel insights into the role of PEC‐Exo in the repair of kidney injury and new ideas for renal fibrosis intervention.
- 15 June 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 561, 119750
Urinary exosomal mRNAs as biomarkers for predicting the therapeutic effect of renin-angiotensin system inhibitors in IgA nephropathy patients
- 15 June 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 561, 119750
Urinary exosomal mRNAs as biomarkers for predicting the therapeutic effect of renin-angiotensin system inhibitors in IgA nephropathy patients